Cystic Fibrosis
Pathogenesis
click to edit
Incidence and Prevalence
- More than 30,000 people in the U.S. currently have CF
- Approximately 1,000 new cases are diagnosed each year in the U.S.
- About 70,000 CF cases worldwide
- Most CF patients are 18 years or older
- About 75% of patients were diagnosed by the time they were 2 years old
Risk Factors
The biggest risk factor of CF is the genetic mutation that patients may inherit.
CF is most common in people with Northern European ancestry
Incidence:
- 25% of children in the U.S. are diagnosed with CF (1 in 4 children)
- 50% of children in the U.S. are carriers of the CF gene
- 25% of children in the U.S. will not carry the CF gene
Having Cystic Fibrosis increases the risk for lung infections, constant coughing, damaged airways and even respiratory failure.
When CF also affects the mucus in the digestive tract, there is an increased risk for malnutrition; making it very difficult for the patient to reach a healthy weight. The reason for this malnutrition risk, is that when the mucus coats certain enzymes in the digestive tract, they are unable to absorb nutrients. When the patient consumes food, their body is not absorbing any of its nutrients.
click to edit
In most cases, CF affects the lungs and bronchial tubes the most. Typically, mucus dehydration in the airways initiates the disease.
While CF has a major effect on the lungs, the thick mucus that is produced by this disease can also be found in the digestive system, sweat glands, and reproductive tract. This can lead to malnutrition and poor growth in most pediatric patients because the mucus in their digestive tract is so thick, that the enzymes located there become trapped and cannot absorb nutrients. Many pediatric patients will present with very slow growth even they may be eating an adequate amount of food.
Cystic Fibrosis is caused by a mutation in the Cystic Fibrosis Transmembrane Conductance Regulator gene (Cftr). The role of Cftr proteins is to control the ions that pass through the cell membrane. Typically, when a Cftr protein becomes irregularly folded, it does not allow the plasma membrane to properly bring Chloride to the cell; which therefore does not bring enough water into the cell. This results in cells that produce mucus that is too thick due to the abnormal amounts of sodium and chloride at the cell membrane.
Diagnostics
Clinical Manifestations
Sources
When CF is suspected in a patient, a sweat test will typically be done. To perform the sweat test, the chemical Pilocarpine and a small electrical stimulation will be applied to an area of the arm or leg. Pilocarpine combined with the electrical stimulation, will stimulate sweat production in that area. The sweat will be collected for about 30 minutes, using a piece of filter paper or gauze. The results of this test will show how much Chloride is in the sweat. This is because patients with CF have more chloride in their sweat than patients without CF.
Results of Sweat Test and what they mean:
Less than 29 mmol/L of Chlorine in sweat - CF is very unlikely
Between 30-59 mmol/L of Chlorine in sweat - CF is possible, further testing should be done
Greater than or equal to 60 mmol/L - CF is very likely
Newborns may also be screened for CF and this will be done only a few days after birth. A heel prick is done to obtain a small blood sample; this blood sample is then placed on a Guthrie card. The Guthrie card is able to test the blood for levels of IRT - Immunoreactive Trypsinogen. IRT is an enzyme produced by the pancreas, and if the levels of this enzyme are high, CF is very likely.
Respiratory Signs and Symptoms:
- Persistent cough with thick mucous production
- Wheezing
- Difficulty breathing with exercise
- Multiple lung infections
- Multiple cases of sinusitis, or inflamed nasal passages causes the patient to feel like they are always congested
Digestive Signs and Symptoms:
- Foul-smelling and greasy stool
- Insufficient weight gain
- Intestinal blockages: common in newborns with CF
- Chronic constipation
Some of these signs and symptoms may occur within a few weeks of birth, or may not appear until childhood, or adulthood.
Treatments
Goals of Treatment:
- Preventing lung infections
- Removing mucus from the lungs
- Treating intestinal blockages
- Preventing malnourishment
Medications:
- Medications for treating gene mutations
- Antibiotics for lung infections such as Penicillins
- Anti-Inflammatory drugs for the lung airways: Prednisone or Hydrocortisone
- Hypertonic Saline: thins mucous and helps the patient cough up mucous more easily
- Bronchodilators such as Albuterol
- Stool softeners for patients with constipation
- Pancreatic enzymes to help absorb nutrients
- Antacids which improve pancreatic enzymes
- Diabetic and liver disease drugs if needed
Techniques for Clearing the Airways:
- Clapping hands on the back of the patient to loosen mucous
- Breathing exercises
- Vibrating vest to loosen mucous
- Exercise can help the lungs work up extra mucous
- Oxygen Therapy if needed
- Feeding tube for those with nutrient deficiencies as a result of a build up of mucous in the digestive tract
- Lung transplant in severe cases
- Liver transplant in severe cases
About Cystic Fibrosis. (n.d.). Retrieved October 02, 2020, from http://cff.org/What-is-CF/About-Cystic-Fibrosis/
Bodas, M., & Vij, N. (2019, January 09). Adapting Proteostasis and Autophagy for Controlling the Pathogenesis of Cystic Fibrosis Lung
Disease. Retrieved October 02, 2020, from
http://www.frontiersin.org/articles/10.3389/fphar.2019.00020/full
Cystic fibrosis. (2020, March 14). Retrieved October 02, 2020 from http://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/symptoms-causes/syc-20353700
Sweat Test. (n.d.). Retrieved October 31, 2020, from https://www.cff.org/What-is-CF/Testing/Sweat-Test/
Newborn Screening for CF. (n.d.). Retrieved October 31, 2020, from https://www.cff.org/What-is-CF/Testing/Newborn-Screening-for-CF/
Cystic fibrosis. (2020, March 14). Retrieved October 31, 2020, from https://www.mayoclinic.org/diseases-conditions/cystic-fibrosis/diagnosis-treatment/DRI-20353706